STING1 and neoplasm: Despite the failure of DMXAA [103], some novel STING agonists, such as di-ABZI, MSA-2, and manganese, exhibit potent antitumor activity in murine tumor models, which are undergoing clinical evaluations (Table 2) [104–108].